WYNYARD, UK, Feb. 22, 2022 /PRNewswire/ --
Fourth Quarter 2021 Highlights
- Net income attributable to Venator of $14 million compared to net loss of $58 million in the prior year period
- Adjusted EBITDA of $40 million
compared to $25 million in the prior
year period
- Net cash provided by operating activities was $17 million and free cash flow was $(9) million
- Diluted income per share of $0.13
and adjusted diluted loss per share of $0.05
- Compared to the third quarter of 2021, TiO2 average
selling prices increased 6% in local currency and TiO2
sales volumes were 10% lower, primarily due to seasonality
Full-Year 2021 Highlights
- Net loss attributable to Venator of $77
million compared to $112
million in the prior year
- Adjusted EBITDA of $180 million
compared to $136 million in the prior
year
- Net cash provided by operating activities of $19 million and free cash flow of $(54) million
- Diluted loss per share of $0.72
and adjusted diluted loss per share of $(0.01)
- Completed valuation of largest pension plan, expect more than
$20 million in future annual cash
savings
- Delivered an incremental $14
million of adjusted EBITDA improvements as part of our
business improvement programs in 2021
|
|
Three months
ended
|
|
Twelve months
ended
|
|
|
December
31,
|
|
September
30,
|
|
December
31,
|
(In millions, except per share amounts)
|
|
2021
|
|
2020
|
|
2021
|
|
2021
|
|
2020
|
Revenues
|
|
$
535
|
|
$
476
|
|
$
557
|
|
$
2,212
|
|
$
1,938
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
attributable to Venator
|
|
$
14
|
|
$
(58)
|
|
$
(47)
|
|
$
(77)
|
|
$
(112)
|
Adjusted net (loss)
income(2)
|
|
$
(5)
|
|
$
(13)
|
|
$
3
|
|
$
(1)
|
|
$
(22)
|
Adjusted
EBITDA(1)
|
|
$
40
|
|
$
25
|
|
$
48
|
|
$
180
|
|
$
136
|
|
|
|
|
|
|
|
|
|
|
|
Diluted income (loss)
per share
|
|
$
0.13
|
|
$
(0.54)
|
|
$
(0.44)
|
|
$
(0.72)
|
|
$
(1.05)
|
Adjusted diluted (loss)
earnings per share(1). (4)
|
|
$
(0.05)
|
|
$
(0.12)
|
|
$
0.03
|
|
$
(0.01)
|
|
$
(0.21)
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by
operating activities
|
|
$
17
|
|
$
34
|
|
$
7
|
|
$
19
|
|
$
34
|
Free cash
flow(3)
|
|
$
(9)
|
|
$
19
|
|
$
(13)
|
|
$
(54)
|
|
$
(35)
|
Venator Materials PLC ("Venator") (NYSE: VNTR) today reported
fourth quarter 2021 results with revenues of $535 million, net income attributable to Venator
of $14 million, adjusted net loss of
$5 million and adjusted EBITDA of
$40 million.
Simon Turner, President and
CEO of Venator, commented:
"In 2021 demand recovered and remained strong throughout the
year. Notwithstanding pressure on our supply chains, sales volumes
increased 5% and average selling prices increased 7%. We have
incurred significant cost inflation from raw materials, energy and
shipping which we have mitigated through a range of pricing actions
and cost control.
"In 2021, we continued to make structural improvements to our
cash uses, including a revaluation of our largest pension plan from
which we expect more than $20 million
in future annual cash savings. We also delivered $14 million benefits from our business
improvement program; actions are substantively complete to deliver
the full benefits of the program.
"We are increasing production to meet the requirements of our
customers for all our products throughout 2022. We continue to
increase our selling prices to align with the inflationary cost
environment. TiO2 fundamentals remain intact and we are
committed to expanding our margins and improving our cash flow
profile."
Segment Analysis for 4Q21 Compared to 4Q20
Titanium Dioxide
The Titanium Dioxide segment generated revenues of $406 million in the three months ended
December 31, 2021, an increase of
$58 million, or 17%, compared to the
same period in 2020. The increase was primarily due to a 20%
increase in the average TiO2 selling price, partially
offset by a 2% decrease in sales volumes and a 1% unfavorable
impact of foreign currency translation, while mix and other was
flat. The decrease in volumes reflects strong demand in the fourth
quarter of 2020 as the global economy emerged from COVID-19
shutdowns as well as decreased volumes in the current year period
due to plant maintenance.
Adjusted EBITDA for the Titanium Dioxide segment was
$35 million in the three months ended
December 31, 2021, an increase of
$10 million compared to the same
period in 2020. The increase was primarily a result of higher
revenue and $6 million of savings
from our business improvement program. These increases were
partially offset by an increase in raw material, energy, shipping
and maintenance costs and the impact of non-recurring savings
during the same period in 2020 as a result of actions taken to
reduce costs during the COVID-19 pandemic.
Performance Additives
The Performance Additives segment generated revenues of
$129 million in the three months
ended December 31, 2021, an increase
of $1 million, or 1%, compared to the
same period in 2020. This increase was a result of an 8% increase
in average selling price partially offset by a 5% decrease in
revenue from our water treatment business, which was sold in the
second quarter of 2021, a 2% decrease in sales volumes, while the
impact of foreign exchange and mix and other was flat. The decrease
in volume was primarily driven by strong demand in the fourth
quarter of 2020 which normalized in the fourth quarter of 2021.
Adjusted EBITDA for the Performance Additives segment was
$19 million in the three months ended
December 31, 2021, an increase of
$4 million compared to the same
period in 2020. The increase in adjusted EBITDA was primarily
related to higher revenue and a $1
million benefit from our business improvement program,
partially offset by an increase in shipping and energy costs.
Corporate and Other
Corporate and other represents expenses which are not allocated to
our segments. Losses from Corporate and other were $14 million, or $1
million lower for the three months ended December 31, 2021 compared to the same period in
2020 due to benefits from our business improvement program.
Tax Items
We recorded an income tax benefit of $45
million and $31 million for
the three and twelve months ended December
31, 2021, respectively, compared to an income tax expense of
$9 million and $12 million for the three and twelve months ended
December 31, 2020, respectively.
$47 million of tax benefit was
recognized in the fourth quarter of 2021 in connection with
recognizing certain net deferred tax assets as a result of
releasing a tax valuation allowance. Our adjusted effective tax
rate was unchanged at 35% for the full year 2021 and full year
2020.
Our income taxes are significantly affected by the mix of income
and losses in tax jurisdictions and valuation allowances in certain
jurisdictions in which we operate. In 2022, we expect to see an
adjusted effective tax rate of approximately 35%. We continue to
expect that our adjusted long-term effective tax rate will be
approximately 15% to 20%.
Liquidity and Capital Resources
As of December 31, 2021, we had cash
and cash equivalents of $156 million
compared with $220 million as of
December 31, 2020. In addition, we
have in place an undrawn asset based revolving credit facility
available for our working capital needs and general corporate
purposes with an availability of $201
million as of December 31,
2021. As of December 31, 2021,
net debt was $798 million compared to
$737 million as of December 31, 2020.
Capital expenditures totaled $26
million in the fourth quarter of 2021 and $73 million in the full year 2021. We expect
capital expenditures in 2022 to total approximately $85 to $95 million.
Earnings Conference Call Information
We will hold a conference call to discuss our fourth quarter and
full-year 2021 results on, Tuesday February 22, 2022, at 08:00
a.m. ET.
Call-in numbers for the
conference call:
|
|
U.S.
participants
|
1-833-366-1118
|
International
participants
|
1-412-902-6770
|
(No passcode
required)
|
|
In order to facilitate the registration process, you may use the
following link to pre-register for the conference call. Callers who
pre-register will be given a unique PIN and separate call-in number
to gain immediate access to the call and bypass the live operator.
To pre-register, please go to:
https://dpregister.com/sreg/10163189/f0d3f802e6
Webcast Information
The conference call will be available via webcast and can be
accessed from the company's website at
venatorcorp.com/investor-relations.
Replay Information
The conference call will be available for replay beginning
February 22, 2022 and ending March 1,
2022.
Call-in numbers for the
replay:
|
|
U.S.
participants
|
1-877-344-7529
|
International
participants
|
1-412-317-0088
|
Passcode
|
9937974
|
Upcoming Conferences
During the first quarter of 2022, a member of management is
expected to present at the J.P. Morgan Global High Yield &
Leveraged Finance Conference on March
1 and at the Bank of America Merrill Lynch Global
Agriculture and Materials Conference on March 2. A webcast of the presentations, if
applicable, along with accompanying materials will be available at
venatorcorp.com/investor-relations.
Table 1 — Results of
Operations
|
|
|
|
Three months
ended
|
|
Twelve months
ended
|
|
|
December
31,
|
|
December
31,
|
(In millions, except per share amounts)
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
Revenues
|
|
$
535
|
|
$
476
|
|
$
2,212
|
|
$
1,938
|
Cost of goods
sold
|
|
491
|
|
442
|
|
2,020
|
|
1,778
|
Operating
expenses
|
|
53
|
|
49
|
|
182
|
|
170
|
Restructuring,
impairment, and plant closing and transition costs
|
|
8
|
|
33
|
|
68
|
|
58
|
Operating
loss
|
|
(17)
|
|
(48)
|
|
(58)
|
|
(68)
|
Interest expense,
net
|
|
(15)
|
|
(15)
|
|
(59)
|
|
(52)
|
Other income
|
|
2
|
|
15
|
|
12
|
|
27
|
Loss before income
taxes
|
|
(30)
|
|
(48)
|
|
(105)
|
|
(93)
|
Income tax benefit
(expense)
|
|
45
|
|
(9)
|
|
31
|
|
(12)
|
Net income
(loss)
|
|
15
|
|
(57)
|
|
(74)
|
|
(105)
|
Net income attributable
to noncontrolling interests
|
|
(1)
|
|
(1)
|
|
(3)
|
|
(7)
|
Net income (loss)
attributable to Venator
|
|
$
14
|
|
$
(58)
|
|
$
(77)
|
|
$
(112)
|
|
|
|
|
|
|
|
|
|
Adjusted
EBITDA(1)
|
|
$
40
|
|
$
25
|
|
$
180
|
|
$
136
|
Adjusted net
loss(1)
|
|
$
(5)
|
|
$
(13)
|
|
$
(1)
|
|
$
(22)
|
|
|
|
|
|
|
|
|
|
Basic & diluted
earnings (loss) per share
|
|
$
0.13
|
|
$
(0.54)
|
|
$
(0.72)
|
|
$
(1.05)
|
Adjusted basic &
diluted loss per share(1,4)
|
|
$
(0.05)
|
|
$
(0.12)
|
|
$
(0.01)
|
|
$
(0.21)
|
|
|
|
|
|
|
|
|
|
Ordinary share
information:
|
|
|
|
|
|
|
|
|
Basic shares
outstanding
|
|
107.3
|
|
106.7
|
|
107.2
|
|
106.7
|
Diluted shares
outstanding
|
|
107.7
|
|
106.7
|
|
107.2
|
|
106.7
|
|
See end of press
release for footnote explanations
|
Table 2 — Results of
Operations by Segment
|
|
|
|
Three months
ended
|
|
|
|
Twelve months
ended
|
|
|
|
|
December
31,
|
|
Better
/
|
|
December
31,
|
|
Better
/
|
(In millions)
|
|
2021
|
|
2020
|
|
(Worse)
|
|
2021
|
|
2020
|
|
(Worse)
|
Segment
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
Titanium
Dioxide
|
|
$
406
|
|
$
348
|
|
17%
|
|
$
1,665
|
|
$
1,431
|
|
16%
|
Performance
Additives
|
|
129
|
|
128
|
|
1%
|
|
547
|
|
507
|
|
8%
|
Total
|
|
$
535
|
|
$
476
|
|
12%
|
|
$
2,212
|
|
$
1,938
|
|
14%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Adjusted
EBITDA(1):
|
|
|
|
|
|
|
|
|
|
|
|
|
Titanium
Dioxide
|
|
$
35
|
|
$
25
|
|
40%
|
|
$
165
|
|
$
127
|
|
30%
|
Performance
Additives
|
|
19
|
|
15
|
|
27%
|
|
65
|
|
55
|
|
18%
|
Corporate and
other
|
|
(14)
|
|
(15)
|
|
7%
|
|
(50)
|
|
(46)
|
|
(9)%
|
Total
|
|
$
40
|
|
$
25
|
|
60%
|
|
$
180
|
|
$
136
|
|
32%
|
|
See end of press
release for footnote explanations
|
Table 3 — Factors
Impacting Sales Revenue
|
|
|
Three months
ended
|
|
December 31, 2021
vs. 2020
|
|
Average Selling Price(a)
|
|
|
|
|
|
|
|
|
|
Local
Currency
|
|
Exchange
Rate
|
|
Sales Mix
& Other
|
|
Sales
Volume(b)
|
|
Divestitures
(c)
|
|
Total
|
Titanium
Dioxide
|
20%
|
|
(1)%
|
|
—%
|
|
(2)%
|
|
—%
|
|
17%
|
Performance
Additives
|
8%
|
|
—%
|
|
—%
|
|
(2)%
|
|
(5)%
|
|
1%
|
Total
Company
|
17%
|
|
(1)%
|
|
—%
|
|
(2)%
|
|
(2)%
|
|
12%
|
|
|
Twelve months
ended
|
|
December 31, 2021
vs. 2020
|
|
Average Selling Price(a)
|
|
|
|
|
|
|
|
|
|
Local
Currency
|
|
Exchange
Rate
|
|
Sales Mix
& Other
|
|
Sales
Volume(b)
|
|
Divestitures
(c)
|
|
Total
|
Titanium
Dioxide
|
8%
|
|
3%
|
|
—%
|
|
5%
|
|
—%
|
|
16%
|
Performance
Additives
|
3%
|
|
2%
|
|
1%
|
|
5%
|
|
(3)%
|
|
8%
|
Total
Company
|
7%
|
|
3%
|
|
—%
|
|
5%
|
|
(1)%
|
|
14%
|
|
|
(a)
|
Excludes revenues from
tolling arrangements, by-products and raw materials
|
(b)
|
Excludes sales volumes
of by-products and raw materials
|
(c)
|
Our water treatment
business was disposed of in the second quarter of 2021
|
Table 4 —
Reconciliation of U.S. GAAP to Non-GAAP Measures
|
|
|
|
EBITDA
|
|
Net Income
(Loss)
|
|
Diluted Earnings
(Loss) Per Share
|
|
|
Three months
ended
|
|
Three months
ended
|
|
Three months
ended
|
|
|
December
31,
|
|
December
31,
|
|
December
31,
|
(In millions, except per share amounts)
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
Net income
(loss)
|
|
$
15
|
|
$
(57)
|
|
$
15
|
|
$
(57)
|
|
$
0.14
|
|
$
(0.53)
|
Net income attributable
to noncontrolling interests
|
|
(1)
|
|
(1)
|
|
(1)
|
|
(1)
|
|
(0.01)
|
|
(0.01)
|
Net income (loss)
attributable to Venator
|
|
14
|
|
(58)
|
|
14
|
|
(58)
|
|
0.13
|
|
(0.54)
|
Interest expense,
net
|
|
15
|
|
15
|
|
|
|
|
|
|
|
|
Income tax (benefit)
expense
|
|
(45)
|
|
9
|
|
|
|
|
|
|
|
|
Depreciation and
amortization
|
|
30
|
|
29
|
|
|
|
|
|
|
|
|
Business acquisition
and integration credits
|
|
1
|
|
—
|
|
1
|
|
—
|
|
0.01
|
|
—
|
Separation
gain
|
|
3
|
|
(10)
|
|
3
|
|
(10)
|
|
0.03
|
|
(0.09)
|
Loss/(gain) on
disposition of businesses/assets
|
|
7
|
|
(1)
|
|
7
|
|
(1)
|
|
0.07
|
|
(0.01)
|
Certain legal
expenses/settlements
|
|
1
|
|
3
|
|
1
|
|
3
|
|
0.01
|
|
0.03
|
Amortization of pension
and postretirement actuarial losses
|
|
2
|
|
3
|
|
2
|
|
3
|
|
0.02
|
|
0.03
|
Net plant incident
costs
|
|
4
|
|
2
|
|
4
|
|
2
|
|
0.04
|
|
0.02
|
Restructuring,
impairment, plant closing and transition costs
|
|
8
|
|
33
|
|
8
|
|
33
|
|
0.07
|
|
0.31
|
Income tax
adjustments(2)
|
|
—
|
|
—
|
|
(45)
|
|
15
|
|
(0.42)
|
|
0.14
|
Adjusted(1)
|
|
$
40
|
|
$
25
|
|
$
(5)
|
|
$
(13)
|
|
$
(0.05)
|
|
$
(0.12)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted income tax
expense(2)
|
|
|
|
|
|
$ —
|
|
$
(6)
|
|
|
|
|
Net income attributable
to noncontrolling interests, net of tax
|
|
|
|
|
|
1
|
|
1
|
|
|
|
|
Adjusted pre-tax
loss(1)
|
|
|
|
|
|
$
(4)
|
|
$
(18)
|
|
|
|
|
Adjusted effective
tax rate
|
|
|
|
|
|
35%
|
|
35%
|
|
|
|
|
|
|
|
EBITDA
|
|
Net Income
(Loss)
|
|
Diluted Earnings
(Loss) Per Share
|
|
|
Three months
ended
|
|
Three months
ended
|
|
Three months
ended
|
|
|
September
30,
|
|
September
30,
|
|
September
30,
|
(In millions, except per share amounts)
|
|
2021
|
|
2021
|
|
2021
|
Net
loss
|
|
$
(47)
|
|
$
(47)
|
|
$
(0.44)
|
Net income attributable
to noncontrolling interests
|
|
—
|
|
—
|
|
—
|
Net loss
attributable to Venator
|
|
(47)
|
|
(47)
|
|
(0.44)
|
Interest expense,
net
|
|
15
|
|
|
|
|
Income tax
expense
|
|
4
|
|
|
|
|
Depreciation and
amortization
|
|
29
|
|
|
|
|
Certain legal
expenses/settlements
|
|
3
|
|
3
|
|
0.03
|
Amortization of pension
and postretirement actuarial losses
|
|
3
|
|
3
|
|
0.03
|
Net plant incident
costs
|
|
6
|
|
6
|
|
0.06
|
Restructuring,
impairment, plant closing and transition costs
|
|
35
|
|
35
|
|
0.33
|
Income tax
adjustments(2)
|
|
—
|
|
3
|
|
0.03
|
Adjusted(1)
|
|
$
48
|
|
$
3
|
|
$
0.03
|
|
|
|
|
|
|
|
Adjusted income tax
expense(2)
|
|
|
|
$
1
|
|
|
Net income attributable
to noncontrolling interests, net of tax
|
|
|
|
—
|
|
|
Adjusted pre-tax
income(1)
|
|
|
|
$
4
|
|
|
Adjusted effective
tax rate
|
|
|
|
35%
|
|
|
|
|
|
|
|
|
|
|
|
|
EBITDA
|
|
Net Income
(Loss)
|
|
Diluted Earnings
(Loss) Per Share
|
|
|
Twelve months
ended
|
|
Twelve months
ended
|
|
Twelve months
ended
|
|
|
December
31,
|
|
December
31,
|
|
December
31,
|
(In millions, except per share amounts)
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
Net
loss
|
|
$
(74)
|
|
$
(105)
|
|
$
(74)
|
|
$
(105)
|
|
$
(0.69)
|
|
$
(0.98)
|
Net income attributable
to noncontrolling interests
|
|
(3)
|
|
(7)
|
|
(3)
|
|
(7)
|
|
(0.03)
|
|
(0.07)
|
Net loss
attributable to Venator
|
|
(77)
|
|
(112)
|
|
(77)
|
|
(112)
|
|
(0.72)
|
|
(1.05)
|
Interest expense,
net
|
|
59
|
|
52
|
|
|
|
|
|
|
|
|
Income tax (benefit)
expense
|
|
(31)
|
|
12
|
|
|
|
|
|
|
|
|
Depreciation and
amortization
|
|
119
|
|
114
|
|
|
|
|
|
|
|
|
Business acquisition
and integration expenses
|
|
1
|
|
1
|
|
1
|
|
1
|
|
0.01
|
|
0.01
|
Separation loss
(gain)
|
|
3
|
|
(10)
|
|
3
|
|
(10)
|
|
0.03
|
|
(0.09)
|
Loss (gain) on
disposition of businesses/assets
|
|
9
|
|
(5)
|
|
9
|
|
(5)
|
|
0.08
|
|
(0.05)
|
Certain legal
expenses/settlements
|
|
5
|
|
6
|
|
5
|
|
6
|
|
0.05
|
|
0.06
|
Amortization of pension
and postretirement actuarial losses
|
|
11
|
|
13
|
|
11
|
|
13
|
|
0.10
|
|
0.12
|
Net plant incident
costs
|
|
13
|
|
7
|
|
13
|
|
7
|
|
0.12
|
|
0.07
|
Restructuring,
impairment, plant closing and transition costs
|
|
68
|
|
58
|
|
68
|
|
58
|
|
0.63
|
|
0.54
|
Income tax
adjustments(2)
|
|
—
|
|
—
|
|
(34)
|
|
20
|
|
(0.32)
|
|
0.19
|
Adjusted(1)
|
|
$
180
|
|
$
136
|
|
$
(1)
|
|
$
(22)
|
|
$
(0.01)
|
|
$
(0.21)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted income tax
benefit (expense)(2)
|
|
|
|
|
|
$ 3
|
|
$
(8)
|
|
|
|
|
Net income attributable
to noncontrolling interests, net of tax
|
|
|
|
|
|
3
|
|
7
|
|
|
|
|
Adjusted pre-tax
income (loss)(1)
|
|
|
|
|
|
$
5
|
|
$
(23)
|
|
|
|
|
Adjusted effective
tax rate
|
|
|
|
|
|
35%
|
|
35%
|
|
|
|
|
|
See end of press
release for footnote explanations
|
Table 5 — Selected
Balance Sheet Items
|
|
|
|
December
31,
|
|
September
30,
|
|
December
31,
|
(In millions)
|
|
2021
|
|
2021
|
|
2020
|
Cash
|
|
$
156
|
|
$
161
|
|
$
220
|
Accounts and notes
receivable, net
|
|
371
|
|
394
|
|
324
|
Inventories
|
|
478
|
|
418
|
|
440
|
Prepaid and other
current assets
|
|
84
|
|
80
|
|
73
|
Property, plant and
equipment, net
|
|
848
|
|
869
|
|
947
|
Other assets
|
|
427
|
|
380
|
|
353
|
Total
assets
|
|
$
2,364
|
|
$
2,302
|
|
$
2,357
|
|
|
|
|
|
|
|
Accounts
payable
|
|
$
377
|
|
$
319
|
|
$
262
|
Other current
liabilities
|
|
131
|
|
127
|
|
126
|
Current portion of
debt
|
|
5
|
|
5
|
|
7
|
Long-term
debt
|
|
949
|
|
949
|
|
950
|
Non-current payable to
affiliates
|
|
21
|
|
17
|
|
17
|
Other
liabilities
|
|
313
|
|
364
|
|
371
|
Total equity
|
|
568
|
|
521
|
|
624
|
Total liabilities
and equity
|
|
$
2,364
|
|
$
2,302
|
|
$
2,357
|
Table 6 —
Outstanding Debt
|
|
|
|
December
31,
|
|
September
30,
|
|
December
31,
|
(In millions)
|
|
2021
|
|
2021
|
|
2020
|
Debt:
|
|
|
|
|
|
|
Term Loan
Facility
|
|
$
356
|
|
$
357
|
|
$
359
|
Senior Secured
Notes
|
|
217
|
|
216
|
|
215
|
Senior Unsecured
Notes
|
|
372
|
|
372
|
|
372
|
Other debt
|
|
9
|
|
9
|
|
11
|
Total debt -
excluding affiliates
|
|
$
954
|
|
$
954
|
|
$
957
|
Total cash
|
|
156
|
|
161
|
|
220
|
Net debt - excluding
affiliates (5)
|
|
$
798
|
|
$
793
|
|
$
737
|
Table 7 — Summarized
Statement of Cash Flows
|
|
|
|
Three months
ended
|
|
Twelve months
ended
|
|
|
December
31,
|
|
December
31,
|
(In millions)
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
Total cash at
beginning of period
|
|
$
161
|
|
$
208
|
|
$
220
|
|
$
55
|
Net cash provided by
operating activities
|
|
17
|
|
34
|
|
19
|
|
34
|
Net cash used in
investing activities
|
|
(13)
|
|
(21)
|
|
(60)
|
|
(64)
|
Net cash (used in)
provided by financing activities
|
|
(9)
|
|
(3)
|
|
(21)
|
|
192
|
Effect of exchange rate
changes on cash
|
|
—
|
|
2
|
|
(2)
|
|
3
|
Total cash at end of
period
|
|
$
156
|
|
$
220
|
|
$
156
|
|
$
220
|
|
|
|
|
|
|
|
|
|
Supplemental cash
flow information:
|
|
|
|
|
|
|
|
|
Cash paid for
interest
|
|
$
(4)
|
|
$
(4)
|
|
$
(62)
|
|
$
(39)
|
Cash paid for income
taxes
|
|
(9)
|
|
(3)
|
|
(14)
|
|
(3)
|
Capital
expenditures
|
|
(26)
|
|
(15)
|
|
(73)
|
|
(69)
|
Depreciation and
amortization
|
|
30
|
|
29
|
|
119
|
|
114
|
Restructuring
|
|
(4)
|
|
(3)
|
|
(11)
|
|
(10)
|
Net cash flows
associated with Pori
|
|
(2)
|
|
(5)
|
|
(12)
|
|
(8)
|
|
|
|
|
|
|
|
|
|
Changes in primary
working capital:
|
|
|
|
|
|
|
|
|
Accounts and notes
receivable
|
|
14
|
|
(6)
|
|
(65)
|
|
14
|
Inventories
|
|
(68)
|
|
15
|
|
(60)
|
|
102
|
Accounts
payable
|
|
56
|
|
36
|
|
120
|
|
(77)
|
Total cash provided
by (used in) primary working capital
|
|
$
2
|
|
$
45
|
|
$
(5)
|
|
$
39
|
|
|
|
Three months
ended
|
|
Twelve months
ended
|
|
|
December
31,
|
|
December
31,
|
(In
millions)
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
Free cash
flow(3):
|
|
|
|
|
|
|
|
|
Net cash provided by
operating activities
|
|
$
17
|
|
$
34
|
|
$
19
|
|
$
34
|
Capital
expenditures
|
|
(26)
|
|
(15)
|
|
(73)
|
|
(69)
|
Total free cash
flow(3)
|
|
$
(9)
|
|
$
19
|
|
$
(54)
|
|
$
(35)
|
|
See end of press
release for numbered footnote explanations
|
Footnotes
|
|
|
(1)
|
Our management uses
adjusted EBITDA to assess financial performance. Adjusted EBITDA is
defined as net income/loss before interest income/expense, net,
income tax expense/benefit, depreciation and amortization, and net
income attributable to noncontrolling interests, as well as
eliminating the following adjustments: (a) business acquisition and
integration expense/credits; (b) separation gain/expense; (c)
loss/gain on disposition of businesses/assets; (d) certain legal
expenses/settlements; (e) amortization of pension and
postretirement actuarial losses/gains; (f) net plant incident
costs/credits; and (g) restructuring, impairment, and plant closing
and transition costs/credits. We believe that net income is the
performance measure calculated and presented in accordance with
U.S. GAAP that is most directly comparable to adjusted
EBITDA.
|
|
|
|
We believe adjusted
EBITDA is useful to investors in assessing our ongoing financial
performance and provides improved comparability between periods
through the exclusion of certain items that management believes are
not indicative of our operational profitability and that may
obscure underlying business results and trends. However, this
measure should not be considered in isolation or viewed as a
substitute for net income or other measures of performance
determined in accordance with U.S. GAAP. Moreover, adjusted EBITDA
as used herein is not necessarily comparable to other similarly
titled measures of other companies due to potential inconsistencies
in the methods of calculation. Our management believes this measure
is useful to compare general operating performance from period to
period and to make certain related management decisions. Adjusted
EBITDA is also used by securities analysts, lenders and others in
their evaluation of different companies because it excludes certain
items that can vary widely across different industries or among
companies within the same industry. For example, interest expense
can be highly dependent on a company's capital structure, debt
levels and credit ratings. Therefore, the impact of interest
expense on earnings can vary significantly among companies. In
addition, the tax positions of companies can vary because of their
differing abilities to take advantage of tax benefits and because
of the tax policies of the various jurisdictions in which they
operate. As a result, effective tax rates and tax expense can vary
considerably among companies. Finally, companies employ productive
assets of different ages and utilize different methods of acquiring
and depreciating such assets. This can result in considerable
variability in the relative costs of productive assets and the
depreciation and amortization expense among companies.
|
|
|
|
Nevertheless, our
management recognizes that there are limitations associated with
the use of adjusted EBITDA in the evaluation of us as compared to
net income. Our management compensates for the limitations of using
adjusted EBITDA by using this measure to supplement U.S. GAAP
results to provide a more complete understanding of the factors and
trends affecting the business rather than U.S. GAAP results
alone.
|
|
|
|
In addition to the
limitations noted above, adjusted EBITDA excludes items that may be
recurring in nature and should not be disregarded in the evaluation
of performance. However, we believe it is useful to exclude such
items to provide a supplemental analysis of current results and
trends compared to other periods because certain excluded items can
vary significantly depending on specific underlying transactions or
events, and the variability of such items may not relate
specifically to ongoing operating results or trends and certain
excluded items, while potentially recurring in future periods, may
not be indicative of future results.
|
|
|
|
Adjusted net income
(loss) attributable to Venator Materials PLC ordinary shareholders
is computed by eliminating the after-tax amounts related to the
following from net income/loss attributable to Venator Materials
PLC ordinary shareholders: (a) business acquisition and integration
expenses/adjustments; (b) loss/gain on disposition of
businesses/assets; (c) certain legal expenses/settlements; (d)
amortization of pension and postretirement actuarial losses/gains;
(e) net plant incident costs/credits; and (f) restructuring,
impairment, and plant closing and transition costs/credits. Basic
adjusted net income per share excludes dilution and is computed by
dividing adjusted net income by the weighted average number of
shares outstanding during the period. Adjusted diluted net income
per share reflects all potential dilutive ordinary shares
outstanding during the period increased by the number of additional
shares that would have been outstanding as dilutive
securities.
|
|
|
|
Adjusted net income
(loss) and adjusted net earnings (loss) per share amounts are
presented solely as supplemental information. These measures
exclude similar noncash items as Adjusted EBITDA in order to assist
our investors in comparing our performance from period to period
and as such, bear similar risks as Adjusted EBITDA as documented
above. For that reason, adjusted net income and the related per
share amounts, should not be considered in isolation and should be
considered only to supplement analysis of U.S. GAAP
results.
|
|
|
(2)
|
Income tax expense is
adjusted by the amount of additional tax expense or benefit that we
would accrue if we used non-GAAP results instead of GAAP results in
the calculation of our tax liability, taking into consideration our
tax structure. We use a normalized effective tax rate of 35%, which
reflects the weighted average tax rate applicable under the various
jurisdictions in which we operate. This non-GAAP tax rate
eliminates the effects of non-recurring and period specific items
which are often attributable to restructuring and acquisition
decisions and can vary in size and frequency. This rate is subject
to change over time for various reasons, including changes in the
geographic business mix, valuation allowances, and changes in
statutory tax rates.
|
|
|
|
We eliminate the effect
of significant changes to income tax valuation allowances from our
presentation of adjusted net income to allow investors to better
compare our ongoing financial performance from period to period. We
do not adjust for insignificant changes in tax valuation allowances
because we do not believe it provides more meaningful information
than is provided under GAAP. We believe that our revised approach
enables a clearer understanding of the long-term impact of our tax
structure on post tax earnings.
|
|
|
(3)
|
Management internally
uses a free cash flow measure: (a) to evaluate the Company's
liquidity, (b) to evaluate strategic investments, (c) to evaluate
the Company's ability to incur and service debt. Free cash flow is
not a defined term under U.S. GAAP, and it should not be inferred
that the entire free cash flow amount is available for
discretionary expenditures. Free cash flow is defined as cash flows
provided by (used in) operating activities from continuing
operations less capital expenditures. The company updated its
definition of free cash flow during the third quarter of 2021 to
conform to the definition more commonly used by publicly traded
companies. Prior to the third quarter of 2021, free cash flow was
defined as cash flows provided by (used in) operating activities
from continuing operations and used in investing activities. Prior
period comparatives within this release have been restated for the
updated definition. Free cash flow is typically derived directly
from the Company's consolidated statement of cash flows; however,
it may be adjusted for items that affect comparability between
periods. Free cash flow is presented as supplemental
information.
|
|
|
(4)
|
The potentially
dilutive impact of share-based awards was excluded from the
calculation of earnings per share for the twelve months ended
December 31, 2021 because there is an anti-dilutive effect as we
are in a net loss position.
|
|
|
(5)
|
"Net debt" is not a
defined term under U.S. GAAP. We define net debt as debt (the most
comparable GAAP measure, calculated as long-term obligations plus
short-term borrowings) minus cash and cash equivalents. Management
believes that net debt is an important measure to monitor leverage
and evaluate the balance sheet.
|
About Venator
Venator is a global manufacturer and marketer of chemical products
that comprise a broad range of pigments and additives that bring
color and vibrancy to buildings, protect and extend product life,
and reduce energy consumption. We market our products globally to a
diversified group of industrial customers through two segments:
Titanium Dioxide, which consists of our
TiO2 business, and Performance Additives, which
consists of our functional additives, color pigments and timber
treatment businesses. Based in Wynyard, U.K., Venator employs approximately
3,500 associates and sells its products in more than 110
countries.
Social Media:
Twitter: www.twitter.com/VenatorCorp
Facebook: www.facebook.com/venatorcorp
LinkedIn: www.linkedin.com/company/venator-corp
Cautionary Statement Concerning Forward-Looking
Statements
Certain statements contained in this press release constitute
"forward-looking statements" within the meaning of the U.S. Private
Securities Litigation Reform Act of 1995. These forward- looking
statements represent Venator's expectations or beliefs concerning
future events, and it is possible that the expected results
described in this press release will not be achieved. These forward
looking statements are subject to risks, uncertainties and other
factors, many of which are outside of Venator's control, that could
cause actual results to differ materially from the results
discussed in the forward looking statements, including the impacts
and duration of the global outbreak of the COVID-19 pandemic on the
global economy and all aspects of our business, including our
employees, customers, suppliers, partners, results of operations,
financial condition and liquidity, global economic conditions, our
ability to maintain sufficient working capital, our ability to
access capital markets on favorable terms, the costs associated
with the closure of our Pori facility and execution of our business
improvement programs and initiatives, our ability to realize
financial and operational benefits from our business improvement
plans and initiatives, changes in raw material and energy prices,
interruptions in raw materials and energy, industry production
capacity and operating rates, the supply demand balance for our
products and that of competing products, pricing pressures,
technological developments, legal claims by or against us, changes
in government regulations, including increased manufacturing,
labeling and waste disposal regulations and the classification of
TiO2 as a carcinogen in the EU, management of
materials resulting from our manufacturing process, including
the ability to develop commercial markets in the regions that we
manufacture and out ability to dispose of these materials if
necessary, the impacts of increasing climate change regulations,
geopolitical events, cyberattacks and public health crises.
Any forward-looking statement speaks only as of the date on
which it is made, and, except as required by law, Venator does not
undertake any obligation to update or revise any forward-looking
statement, whether as a result of new information, future events or
otherwise. New factors emerge from time to time, and it is not
possible for Venator to predict all such factors. When considering
these forward-looking statements, you should keep in mind the risk
factors and other cautionary statements in Venator's Annual Report
on Form 20-F for the year ended December 31,
2021 filed with the SEC. The risk factors and other factors
noted therein could cause its actual results to differ materially
from those contained in any forward-looking statement.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/venator-announces-fourth-quarter-and-full-year-2021-results-strong-improvement-in-selling-prices-mitigates-cost-pressures-301487274.html
SOURCE Venator Materials PLC